chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DIARRHEA; FEVER; CHEST PAIN; HEADACHE; VOMITING; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: sometimes general headaches, and other pre-existing medical conditions included: Patient had no known allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, expiry: UNKNOWN) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-JAN-2022, the patient experienced chest pain, headache, and vomiting. Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 19-JAN-2022, the patient experienced diarrhea, and fever. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, chest pain, diarrhea, and fever, and the outcome of vomiting was not reported. This report was non-serious. The suspected product quality complaint has been confirmed to be voided (did not meet PQC criteria as the reporter indicates they were exposed to someone with Covid and they later felt ill but tested negative for Covid. There is no product quality issue described in the information reported. Approval to void this record due to no PQC identified) based on the PQC evaluation/investigation performed. Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non-serious.
Patient felt like they were going to pass out.  Patient appeared unfocused/startled when touched.  LIfted to a stretcher.  BP 135/83.  HR 97.  Reports not eating or drinking anything.  Given crackers and juice.  Observed for 30 minutes.  Reports resolution of symptoms.  BP 126/62, HR 122.
55 yo female received first dose of the Pfizer COVID-19 vaccine on 3/17 at 1309. Pt was observed for 15 minutes without any symptoms. She left the facility, but returned a few minutes later with complaints of dizziness, nausea, thick tongue, and itching palate. Upon assessment, vitals were BP 145/83, HR 83, SpO2 99%. Given diphenhydramine 25 mg solution. Shortly thereafter, pt experienced increasing tongue thickness and chest tightness. Epinephrine 0.3 mg auto injector administered followed by famotidine 20 mg and hydrocortisone 100 mg. Continued dizziness, ear ringing, SpO2 83%. EMS called and patient transferred to the ED. Presented to the ED without symptoms and observed for 4 hours. Discharged home with...
I felt fine after vaccine and only a little fatigued but nothing serious, and about 3-4 days after I started to feel chest pain and that lasted for 2-3 days and I felt like my heartbeat was irregular and I felt flutters and strong heartbeat and it made me anxious. I went to an urgent care while I was on vacation and they didn't know, so when I got back from my trip 2 weeks after the booster, I went to my PCP because I was still having chest pain. They did an EKG which was normal and they said it was a side effect from vaccine mostly in young men and they gave me a steroid and I took the steroids for a few days and then got back to normal. About a month after steroids I got better and only had slight flutter.
No adverse event known. Patient had already received a dose of Fluad on 8/29/2023 at same pharmacy. This was not discovered until after receiving the second dose on 9/16/2023.
Pt recvd 3 doses of Engerix-B 27NOV90, 27DEC90, & 10JUN91 & 25SEP91 it was determined that pt was a non-responder; 2 addtl doses of vax were administered;
Initial report received on 10 December 2006 a health care professional. A 38-year-old female patient had inadvertently received a left deltoid, intramuscular injection of Daptacel, (product not recommended for use in this age group), lot number C2630AA, on 18 August 2006. This product was administered instead of Adacel. The following day, the patient experienced muscle soreness. No testing or examination by a physician was required. The patient took nonsteroidal anti-inflammatory medications as needed. The patient recovered from the event within 96 hours. The reporter in this case is the same as the reporter in cases 2006-02409, 2006-03043, 2006-03045, 2006-03046, 2006-03047, 2006-03048, 2006-03049, 2006-03050, and 2006-03051.
Pt reports within a couple hours he developed a fever and became lethargic; pt took a nap; when he awoke he noticed his sense of smell & taste were gone.
After the immunization in October 2014, I starting experiencing inflammation in the facial area and eyes. My heart was racing 24 hours a day. My hormones became extremely unbearable feeling. I suddenly felt too fearful and ill to get out of bed or leave the house. After all of these months of suffering and hospitals lying and ignoring my symptoms, I have finally found an in-home care doctor's service to help me. For months I had been fighting the inflammation and adverse effects with health foods and herbal teas. I honestly do not know the exact day or time the symptoms began. I only know it was right after the immunization.
fever at around 9 PM 102/ fever it was high as 103/ currently 102.3; anxiety; panic attacks; feeling sick; puked twice; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 08:00 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated, "So I had the vaccine yesterday at 8 AM and I started having symptoms, side effects at about 6 PM. I started having fever at around 9 PM 102, I can't break my fever it was high as 103, my fever is currently 102.3. I am feeling sick, have puked twice now. Once I feel because I had anxiety, panic attacks and then I tried to get my phenergan and puked that up." Outcome of fever was not recovered, other events was unknown.
The first shot I gave the patient, the needle mal-functioned and the vaccine came out of the top of the needle. After completing the 2nd shot, I went to draw up another injection for her husband when he called me back over to the patient. He seemed to think that she blacked out for a second or two cause she stated that she didn't hear him call me back over. She was coherent and able to communicate with me as soon as I got there. She said she was a little clammy, light-headed and felt a little dizzy. I gave her some water to drink and a cold wash cloth on her head. She remained seated for at least 20-30 minutes as I proceeded to administer her husband his vaccine. She seemed to recover pretty quickly, and was surprised because something like this has never happened to her before. She said she was a little thirsty before I even gave her the shot, but not sure if that had any bearing. The couple left after 30 minutes or so and stated they both were fine. I called her before I left work to check on her, but there was no answer so I left a message.
sinus infection; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced SINUSITIS (sinus infection). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. At the time of the report, SINUSITIS (sinus infection) outcome was unknown. PCP put her on Amoxicillin. Bacterial Sinusitis? if so then it's in medical event list      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided.
SEVERE BODY ACHES; DIZZINESS; UNABLE TO GET COMFORTABLE; PAIN IN ARM; MYALGIA; FEVER; SEVERE HEADACHE; NAUSEA; WEAKNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced severe body aches, dizziness, unable to get comfortable, pain in arm, myalgia, fever, headache, nausea, and weakness. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from severe body aches, myalgia, fever, headache, nausea, weakness, dizziness, pain in arm, and unable to get comfortable. This report was non-serious.
The next day, patient had a pruritic rash at the injection site which she describes as hives lasting a few days. A few days after the vaccine she started having shortness of breath and wheeze and intermittent tachycardia, and  continued to have  intermittent shortness of breath and wheeze at rest.
Started to enter skin when patient stated she did not feel good. I pulled needle out without injecting the FLUZONE. Patient fainted for less than a minute. Called 911 as a precaution. Patient stated afterwards the she did not eat breakfast.
Still got them/ Suspected vaccination failure; Still got them; chiken pox; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and chickenpox. On an unknown date, the outcome of the vaccination failure, shingles and chickenpox were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and chickenpox to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 11-SEP-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient had the Chicken pox, the vaccine and still got them. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As it was unclear if the patient experienced chickenpox before or after the Shingles vaccine, hence conservatively captured as event.
patient started feeling dizzy, nauseous, and rash started to develop on her chest. Patient was injected with benadryl IM 50 mg 1ml on her right arm and 911 was called. Five minutes later, patient reported feeling tight on her throat, she was immediately injected with Epipen and help arrived within minutes.
Pt is a 73 yr old male with a past medical hx of seizures, asthma, CAD, TBI was admitted to ASJH-E on 9/19/21 with a co syncopal episode at home. Pt reports COVID19 vaccine 2 doses in April 2021. Pt denies any fever or chills. No co nausea or vomiting or any diarrhea. Pt on admission is afebrile and has wbc count of 3 and creatinine of 0.5. COVID19 positive. CXR showed bilateral lower lobe atelectasis /infiltrate. CT head no acute pathology. Pt is on IV Ceftriaxone and zithromax. Pt is on 2 liters of O2. Pt denies any known COVID19 exposure. No other acute event per nursing staff.
1MAY97 red, splotchy area @ site of vax, warm, sl swollen, sl discomfort;splotchiness extending to hips, lt not tender;pt acting OK;6MAY97 site better swelling & splotchiness gone bruising;
On January 30, 2023 I had the worst nightmare. In my sleep, I woke up thinking that baby mice, moths, insects were covering my body and biting me. I threw the covers off and tried to run. I slipped immediately, got up and ran to the hallway in my condo. It took me several minutes to recall what had just happened. It was a truly scary incident. Never had I experienced a nightmare or dream that would compare. In fact, I cannot remember even having nightmares.
High fever (101), sweating, aches and pains in joints, dizziness, nauseous, irregular heartbeat, & ringing in ears!! Most symptoms still exist!!
On the right thigh there was redness and warmness to the touch. I understand this is normal on the 3rd day after the DTaP the area welted up and he had hives and intense itching. This lasted 2 days.
Information has been received from a registered nurse concerning an employee who was vaccinated with a dose of PNEUMOVAX 23.  Subsequently last year, the patient developed cellulitis.  At the time of the report, the patient's status was unknown.  Follow-up information has been received from a registered nurse who reported that the patient had recovered.  The health care professional contacted during telephone follow-up could not supply the following information:  dates of vaccination/therapy, dose number (if applicable), lot number (if applicable), date of event and hospital name (if applicable).  Additional information has been requested.  This is one of several reports from the same source.
Developed  bacterial infection at site of injection.  PCP believes the vaccine was given to low. Sought medical care at Urgent Care, and PCP.  Received 14 day course of Bactrim-BID.
palm sized area of redness near injection site started after 24 hrs,  resolving by 72 hrs
Employee tested Rubella non-immune; Rubeola immune W/ 1.26 level. Mild rash. Presented w/ rash over entire body, pain in joints, & redness in sclera.
Initial report received from a health care professional on 14 October 2009. A 5 year old male patient with a history of cat and nut tree pollen allergies and mild respiratory illness at the time of vaccination received the following vaccines 11 October 2009: a right deltoid injection of FLUZONE (lot number not reported) and a left deltoid H1N1 (lot number not reported). Approximately 6 hours after vaccination, the patient developed a fever of 101.4 to 103 degrees Fahrenheit, chills, cough, fatigue and loss of appetite. At the time of the report, the patient had not recovered. List of documents held by sender: none.
The first shot, I experienced muscular pain in my right scapula and right hip.  Second vaccination, after 4 days, experience excruciating pain in right scapula and severe arthritis , and severe tendonitis in right arm. Doctor dismissed my pain and said I must have a pinched nerve. I sobbed and told her no, but she wouldn't listen to me. I ended up getting a cortisol shot and that made swelling, which was grotesque,  stop, though the severe tendonitis and severe arthritis lasted for 2 or so more weeks.  5 weeks later, my periods became almost unmanageable.  Pain in left ovary area, non stop heavy heavy bleeding. My period lasted for 5 weeks straight. Then, my period stopped for a day or two, then came again. I had blood work and an ultrasound,  which showed that I have a cyst on my ovary. I was told I need to watch the blood flow from my period because I could hemorrhage and need a D& C.  I still am experiencing pain.
Pt received vaccine 6/27/17, swelling and redness and warmth appeared on 6/29/17. Pt came in and reported on 6/30/17 at injection site.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021 at 5:12 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milligram. On 23-Nov-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.   This case was linked to MOD-2021-402935 (Patient Link).
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer and a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 23-FEB-2011, the patient was administered the ZOSTAVAX by a healthcare provider at a public health facility (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician at a physician's office for the following injury resulting from the patient's ZOSTAVAX use: Shingles. The patient claims damages including: injury to himself, loss of services, loss of consortium, and economic losses. The outcome of the shingles was unknown. Causality related. Additional information has been requested.
pt recv vax & exp bullous skin eruptions p/48hr;skin biopsy suggested bullous pemphigus;3wk p/vax hosp w/lesions & wrist buttock; dx:toxidermia, pemphigus-like;discharged p/ 7 days & symptoms were stated to have resolved.
A report has been received from a Pharmacist concerning a 58 year old, Female subject, who had been receiving Nasal FLUMIST. FLUMIST started on 02-Dec-2012. The patient experienced burning joints, fever, burning up and headaches. The outcome of the event of burning joints, fever, burning up and headaches is unknown. The report was considered to be non-serious. The reporter considered that there was causal relationship between burning joints, fever, burning up and headaches and FLUMIST.
This case was reported by a nurse and described the occurrence of influenza-like symptoms in a 18-year-old male patient who received BEXSERO (batch number 156801A, expiry date August 2017). In October 2016, the patient received the 1st dose of BEXSERO (intramuscular) 0.5 ml. In October 2016, less than a month after receiving BEXSERO, the patient experienced influenza-like symptoms and unwell. On an unknown date, the outcome of the influenza-like symptoms and unwell were unknown. It was unknown if the reporter considered the influenza-like symptoms and unwell to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient reported feeling ill such as experiencing flu like symptoms. The reporter was unable to get more information. The case was linked with cases US2016161492 and US2016GSK196396, reported by the same reporter.
pt recvd vax & 1-2 days later devel a large red, warm area around the site of inject, which extended below the elbow to the upper forearm; pt's lymph node were palpable;
Pain in her stomach; No appetite today; Woke up not feeling good; Major diarrhea; She has a lot of gas, gassy symptoms; Threw up twice; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Pain in her stomach), DECREASED APPETITE (No appetite today), MALAISE (Woke up not feeling good), DIARRHOEA (Major diarrhea) and FLATULENCE (She has a lot of gas, gassy symptoms) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Pain in her stomach), DECREASED APPETITE (No appetite today), MALAISE (Woke up not feeling good), DIARRHOEA (Major diarrhea), FLATULENCE (She has a lot of gas, gassy symptoms) and VOMITING (Threw up twice). The patient was treated with SIMETICONE (GAS-X) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Pain in her stomach), DECREASED APPETITE (No appetite today), MALAISE (Woke up not feeling good), DIARRHOEA (Major diarrhea), FLATULENCE (She has a lot of gas, gassy symptoms) and VOMITING (Threw up twice) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information included "The caller states her mother had gas pills called simethicone (Gas-X)."
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Nausea-Severe, Systemic: Seizure-Medium, Systemic: Shakiness-Medium
While being observed for the "15 minute" period, within 5 minutes of the injection, there was a sudden sharp odor of alcohol and then a metallic taste in my mouth. I then had tingling on the right side of my head, right cheek and then the right side of my tongue went numb. The tongue numbness started to subside after about an hour and a half with tingling on right side of head lasting about one week. I reported to Moderna the next day on 3/1/21 and my general practice doc, some time that week, afraid that I  had a reactivation of Shingles. Spoke to a virologist after that. Historically I have had Shingles some years ago which affected the nerves in my face in the same place. Also, a dental infection many years ago which affected these same nerves. They assured me that Shingles had not re-occurred. I did take the 2 dose Shingrix vaccine in 2019 without any problems. I have never had an allergic reaction to any vaccine previously. I had a swollen lymph node on right arm pit area noticed about a week later.  This lasted about a month.90 days later about May-June 2021 I had a series of hot flashes with sweats and tingling/chills in nipple area of both breasts. This was new and I wondered if related, Have never had this before. Hot flashes during menopause was about 15 years ago and never this intense and no nipple tingling! This has gone away by October 2021